相关实验视频
Updated: Mar 14, 2026

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.6K
单细胞RNA和T细胞受体测序数据联合分析的多模式框架预测T细胞对癌症免疫疗法的反应
Chujun He1,2,3, Matthew Amodio1, Orr Ashenberg4,5
1Eric and Wendy Schmidt Center, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Nature communications
|March 13, 2026
概括
我们开发了TCR-RNA整合模型 (TRIM) 来分析T细胞RNA和T细胞受体 (TCR) 数据. TRIM准确地预测T细胞克隆性和状态,有助于预测癌症治疗反应.
科学领域:
- 免疫学 免疫学 免疫学
- 计算生物学 计算生物学
- 在瘤学瘤学.
背景情况:
- T细胞状态是各种癌症的关键预后标志物.
- 单细胞技术现在允许T细胞RNA和T细胞受体 (TCR) 序列的联合分析.
- 整合这些多式联络数据可以更深入地了解T细胞功能和癌症进展.
研究的目的:
- 引入TCR-RNA整合模型 (TRIM),这是一个用于分析联合RNA-TCR单细胞数据的新型框架.
- 使用集成的多式联络数据预测T细胞克隆性和转录状态.
- 评估TRIM在预测T细胞对癌症治疗和疾病进展的反应方面的实用性.
主要方法:
- 开发了TRIM,一个多模态变量自动编码器框架.
- TRIM学习了基于患者,组织和时间点的共享数据表示.
- 将TRIM应用于来自癌症患者的三个独立数据集 (头癌,结肠直肠癌,胰腺癌).
主要成果:
- TRIM准确地预测了瘤内T细胞的克隆扩张.
- TRIM成功地预测了T细胞的转录状态.
- 在治疗前使用血液或正常组织中的T细胞进行预测是准确的,证明了预测能力.
结论:
- TRIM有效地建模了多模式T细胞数据 (RNA和TCR).
- 该模型在预测T细胞对检查点抑制剂治疗的反应方面具有显著的实用性.
- TRIM为了解癌症中的T细胞动态和预测治疗结果提供了一个强大的工具.
相关概念视频
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
T Cell Activation and Clonal Selection
17.0K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
17.0K
Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells
4.2K
4.2K

